1228 — Canbridge Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Canbridge Pharmaceuticals, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	746	463	137	10.5	66.6
Net Total Accounts Receivable
Net Total Receivables	27.9	19.1	39.5	26.6	22.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	812	505	210	45.4	110
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	29.5	145	109	3.64	0.511
Net Intangible Assets
Other Long Term Assets
Total Assets	893	702	395	117	165
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	186	278	328	483	455
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	199	393	435	591	507
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	693	309	-39.8	-474	-342
Total Liabilities & Shareholders' Equity	893	702	395	117	165
Total Common Shares Outstanding